Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorS.deHaart, T,Mutis
dc.contributor.authorKooijman, S.
dc.date.accessioned2013-02-11T18:01:09Z
dc.date.available2013-02-11
dc.date.available2013-02-11T18:01:09Z
dc.date.issued2013
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/12566
dc.description.abstractAbstract: Immunotherapy is a promising strategy in the fight against cancer, based on the mechanism of action of T cells. However tumors have developed several ways to evade this strategy. This is done by interfering with the intrinsic or extrinsic apoptotic cascade, used by T cells to kill tumor cells. This can be done by interfering with molecules involved in the apoptotic cascade or by interfering with regulators of the apoptotic cascade or, by interfering with regulators of regulators of the apoptotic cascade. This interference leads to a reduced sensitivity to CTL mediated lysis or even to a complete resistance against CTL mediated lysis.
dc.description.sponsorshipUtrecht University
dc.format.extent826628 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.titletumor immune escape: apoptosis resistance induced by the tumor-microenvironment
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsimmunotherapy or resistance to CTL mediated lysis
dc.subject.courseuuDrug Innovation


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record